Robert Lisicki - 23 Jan 2025 Form 4 Insider Report for Cadrenal Therapeutics, Inc. (CVKD)

Role
Director
Signature
/s/ Matthew K. Szot, Attorney-in-fact
Issuer symbol
CVKD
Transactions as of
23 Jan 2025
Transactions value $
$0
Form type
4
Filing time
24 Jan 2025, 18:09:38 UTC
Previous filing
11 Dec 2024
Next filing
03 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVKD Stock Options Award $0 +20K $0.00 20K 23 Jan 2025 Common Stock 20K $19.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest pro rata on a monthly basis over 12 months commencing on February 1, 2025.